PIAS1 may function as an E3 ligase for ligand-activated nuclear receptor peroxisome proliferator-activated receptor (PPAR) gamma, which is modified by SUMO-1 and is a potential target for apoptosis-induction therapy in cancer cells [6]. Here, PIAS1 is linked to cancer.